G
Genuity Science
Genomic information company using sequence data to improve health for people around the world
About Genuity Science
Genuity Science operates in the precision health sector, focusing on genomics to transform healthcare. The company collaborates with hospitals, advocacy groups, academic institutions, and research centers to understand how genetics, environment, and lifestyle influence disease prevention and treatment. By leveraging groundbreaking research, Genuity Science aims to predict, prevent, and treat diseases more precisely, thereby improving lives. The company serves a diverse range of clients, including healthcare providers, researchers, and patients, particularly those with undiagnosed disorders. Its business model revolves around conducting research studies and providing whole genome sequencing services, especially for rare diseases. Revenue is generated through partnerships, research grants, and service fees. Genuity Science is committed to advancing medical breakthroughs and reimagining the future of healthcare.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2013
- Headquarters
- Boston, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 69.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Genetics and genomics, Core AI, Precision Medicine, Health Diagnostics, Disease
- Technology
- Artificial Intelligence, Big Data, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 4 companies, latest Feb 2019
- Capital deployed
- $441M
- Preferred round
- LATE VC
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Aug 2021 | $100M | $100M | HiberCell | — |
| SERIES COther financing | Nov 2018 | $200M | $800M | Ireland Strategic Investment Fund · Sequoia · Temasek · YunFeng Capital | — |
Growth signals
Latest recorded traffic for Genuity Science is 5.4K monthly website visits, up 86.2% over the last three months. Genuity Science's team declined 26.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
DNAnexusMountain View, United StatesCombines expertise in cloud computing and bioinformatics to create a global network for genomic medicine
$600Mvaluation
GRAILMenlo Park, United StatesDeveloping blood tests for early cancer detection high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science
$8Bvaluation
Claritas GenomicsCambridge, United StatesProviding the highest quality testing services for diagnosis of pediatric disorders
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
ARCH Venture Partners
Polaris Partners
YunFeng Capital
Temasek- 3P3W Partners
Amgen Ventures
Sequoia
Series B and later1 investor entered at this stage
Ireland Strategic Investment Fund
Other known investors2 additional known investors
HiberCell
WuXi AppTec
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genuity Science on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genuity Science’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.